Drug intelligence / Profile preview

ATI-9242

Development stage
Phase 1
Lead developer
ARYx Therapeutics
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

ATI-9242 is a novel, atypical antipsychotic small molecule developed for the treatment of schizophrenia. It is a dibenzo(b,f)(1,4)oxazepine derivative designed to provide efficacy similar to clozapine but with fewer adverse effects. The drug acts on multiple neurotransmitter systems, including serotonin (5-HT1A agonist, 5-HT2A antagonist, 5-HT7 modulator), dopamine (D2 antagonist), acetylcholine (stimulant), GABA (modulator), and NMDA receptors (modulator). Its broad mechanism aims to address both positive and negative symptoms of schizophrenia while minimizing side effects commonly associated with other antipsychotics[1][3][4][5].

Other names
ATI 9242ATI9242ATI-9242
02

Targets

HTR7 (5-hydroxytryptamine receptor 7)HTR2A (Serotonin receptor 5-HT2A)DRD2 (Dopamine D2 Receptor)NMDAR (Glutamate receptor ionotropic, NMDA)AChR (Acetylcholine receptor)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))

Beyond the preview

Go deeper on ATI-9242.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATI-9242.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call